thalassemia

(redirected from a-thalassemia)
Also found in: Dictionary, Medical, Encyclopedia.
Related to a-thalassemia: Alpha Thalassemia, Thalassaemia minor
Graphic Thesaurus  🔍
Display ON
Animation ON
Legend
Synonym
Antonym
Related
  • noun

Synonyms for thalassemia

References in periodicals archive ?
Frequency of platelet aggregation defects in children suffering fromg a-thalassemia. Saudi Journal for Health Sciences.; 1(2) (2012).
HbH which is a form of NTDT has a diverse phenotypic presentation depending on the degree of alpha globin chain deficiency which in turn relates to the underlying a-thalassemia mutations with hemolysis being the dominant clinical symptom [1].
In a-thalassemia two genes HB a and HB a at chromosome No.
The a-thalassemias are the most prevalent and widely distributed genetic blood disorders of hemoglobin synthesis in Southeast Asia and particularly in Thailand, affecting 16-30% of Thai population.
YSSXG Can Downregulate the mRNA Expression and Decrease the Activity of DNA Methyltransferase of Patients with a-Thalassemia Disease.
GM06160 also gave anomalous results in testing for a-thalassemia. Southern blot analysis showed an unusual banding pattern with a [zeta]-globin gene probe, with additional smaller bands in BamHI and BglII digests (an EcoRI digest appeared normal).
In comparison, a-thalassemia traits will show no specific characteristics on electrophoresis, HPLC, or CE except for a marginal reduction in [HbA.sub.2] expression.
Co-Existence of Hereditary Pyrimidine 5'-Nucleotidase Deficiency and Heterozygous a-Thalassemia: A Case Presentation.
Others have evaluated its performance with various other technologies12,13 and in the analysis of complicated a-thalassemia and ss-thalassemia syndromes in Southeast Asia14 or rare hemoglobin variants8.
For patient 1, a routine a-globin gene configuration Southern analysis was performed to screen for the presence of the [--.sup.SEA] a-thalassemia deletion, a common amelioration factor of severe ([alpha]-thalassemia (7).
It is prevalent in South-East Asian, Middle Eastern and Mediterranean population but intermediate and severe forms are rare in North America and Northern Europe.1,2 Multiple types of deletions or mutations have been found to influence the clinically observed heterogeneous phenotypes of a-thalassemia cases.3